Clinical Trials in Moshi, Tanzania
9 recruiting
Showing 1–10 of 10 trials
Recruiting
Phase 1Phase 2
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)1,120 enrolled46 locationsNCT02140255
Recruiting
Not Applicable
BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe
OncologyCardiovascular DiseasesRare Diseases+3 more
Technical University of Madrid3,100 enrolled10 locationsNCT06856902
Recruiting
Not Applicable
The P-KIDs CARE Health Systems Intervention in Tanzania
Pediatric Emergency MedicineImplementation ScienceAccidental Injuries+3 more
University of Utah284 enrolled1 locationNCT06075108
Recruiting
Phase 2
Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
Tuberculous Meningitis
National Institute of Allergy and Infectious Diseases (NIAID)330 enrolled18 locationsNCT05383742
Recruiting
Phase 2
PanACEA - STEP2C -01
Pulmonary TuberculosisOther Specified Pulmonary Tuberculosis
Michael Hoelscher390 enrolled10 locationsNCT05807399
Recruiting
Phase 2
Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
Pulmonary Tuberculosis
University College, London2,500 enrolled11 locationsNCT06114628
Recruiting
Fast and Accurate Breast Cancer Diagnosis Using Nanopore Sequencing in Tanzania (Fast-ABCD Sequencing)
Breast Cancer Invasive
University of Bonn100 enrolled1 locationNCT06633276
Recruiting
Treatment Outcomes of Esophageal Cancer
Esophageal Cancer
University of California, San Francisco2,476 enrolled6 locationsNCT05177393
Recruiting
Prospective Urban Rural Epidemiology Study
CancerCardiovascular DiseasesLung Diseases+6 more
Population Health Research Institute200,000 enrolled34 locationsNCT03225586
Recruiting
Phase 3
A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis
TuberculosisHuman Immunodeficiency Virus
Stellah Mpagama414 enrolled1 locationNCT05575518